BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 32014541)

  • 1. Cerebral Revascularization for Moyamoya Syndrome Associated with Sickle Cell Disease: A Systematic Review of the Literature on the Role of Extracranial-Intracranial Bypass in Treating Neurologic Manifestations of Pediatric Patients with Sickle Cell Disease.
    Terrell D; Savardekar AR; Whipple SG; Dossani RH; Spetzler RF; Sun H
    World Neurosurg; 2020 May; 137():62-70. PubMed ID: 32014541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of surgical revascularization for stroke prevention in pediatric patients with sickle cell disease and moyamoya syndrome.
    Yang W; Xu R; Porras JL; Takemoto CM; Khalid S; Garzon-Muvdi T; Caplan JM; Colby GP; Coon AL; Tamargo RJ; Huang J; Ahn ES
    J Neurosurg Pediatr; 2017 Sep; 20(3):232-238. PubMed ID: 28686127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease.
    Griessenauer CJ; Lebensburger JD; Chua MH; Fisher WS; Hilliard L; Bemrich-Stolz CJ; Howard TH; Johnston JM
    J Neurosurg Pediatr; 2015 Jul; 16(1):64-73. PubMed ID: 25837886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pial synangiosis for moyamoya syndrome in children with sickle cell anemia: a comprehensive review of reported cases.
    Kennedy BC; McDowell MM; Yang PH; Wilson CM; Li S; Hankinson TC; Feldstein NA; Anderson RC
    Neurosurg Focus; 2014 Jan; 36(1):E12. PubMed ID: 24380478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical Revascularization for Pediatric Patients with Sickle Cell Disease and Moyamoya Disease in the Prevention of Ischemic Strokes: A Single-Center Case Series and a Systematic Review.
    Aguilar-Salinas P; Hayward K; Santos R; Agarwal V; Sauvageau E; Hanel RA; Aldana PR
    World Neurosurg; 2019 Mar; 123():435-442.e8. PubMed ID: 30496928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes in Patients with Moyamoya Syndrome and Sickle Cell Disease: A Systematic Review.
    Newman S; Boulter JH; Malcolm JG; Pradilla I; Pradilla G
    World Neurosurg; 2020 Mar; 135():165-170. PubMed ID: 31790841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral revascularization surgery reduces cerebrovascular events in children with sickle cell disease and moyamoya syndrome: Results of the stroke in sickle cell revascularization surgery retrospective study.
    Aldana PR; Hanel RA; Piatt J; Han SH; Bansal MM; Schultz C; Gauger C; Pederson JM; Iii JCW; Hulbert ML; Jordan LC; Qureshi A; Garrity K; Robert AP; Hatem A; Stein J; Beydler E; Adelson PD; Greene S; Grabb P; Johnston J; Lang SS; Leonard J; Magge SN; Scott A; Shah S; Smith ER; Smith J; Strahle J; Vadivelu S; Webb J; Wrubel D
    Pediatr Blood Cancer; 2023 Jul; 70(7):e30336. PubMed ID: 37057741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical treatment of moyamoya syndrome in patients with sickle cell anemia: outcome following encephaloduroarteriosynangiosis.
    Hankinson TC; Bohman LE; Heyer G; Licursi M; Ghatan S; Feldstein NA; Anderson RC
    J Neurosurg Pediatr; 2008 Mar; 1(3):211-6. PubMed ID: 18352765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in Overt and Silent Stroke Recurrence Rate Following Cerebral Revascularization Surgery in Children with Sickle Cell Disease and Severe Cerebral Vasculopathy.
    Hall EM; Leonard J; Smith JL; Guilliams KP; Binkley M; Fallon RJ; Hulbert ML
    Pediatr Blood Cancer; 2016 Aug; 63(8):1431-7. PubMed ID: 27106860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct Clinical and Radiographic Phenotypes in Pediatric Patients With Moyamoya.
    Kaseka ML; Slim M; Muthusami P; Dirks PB; Westmacott R; Kassner A; Bhathal I; Williams S; Shroff M; Logan W; Moharir M; MacGregor DL; Pulcine E; deVeber GA; Dlamini N
    Pediatr Neurol; 2021 Jul; 120():18-26. PubMed ID: 33962345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter to the Editor Regarding "Cerebral Revascularization for Moyamoya Syndrome Associated with Sickle Cell Disease: A Systematic Review of the Literature on the Role of Extracranial-Intracranial Bypass in Treating Neurologic Manifestations of Pediatric Patients with Sickle Cell Disease".
    Yu J; Du Q; Chen J
    World Neurosurg; 2020 Jun; 138():582. PubMed ID: 32545006
    [No Abstract]   [Full Text] [Related]  

  • 12. In Reply to the Letter to the Editor Regarding "Cerebral Revascularization for Moyamoya Syndrome Associated with Sickle Cell Disease: A Systematic Review of Literature on the Role of Extracranial-Intracranial Bypass in Treating Neurologic Manifestations of Pediatric Patients with Sickle Cell Disease".
    Terrell D; Savardekar AR; Whipple SG; Sun H
    World Neurosurg; 2020 Jun; 138():583-584. PubMed ID: 32545007
    [No Abstract]   [Full Text] [Related]  

  • 13. Anesthesia for cerebral revascularization for adult moyamoya syndrome associated with sickle cell disease.
    Chong CT; Manninen PH
    J Clin Neurosci; 2011 Dec; 18(12):1709-12. PubMed ID: 21992742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Encephaloduroateriosynangiosis (EDAS) in the management of Moyamoya syndrome in children with sickle cell disease.
    Alamri A; Hever P; Cheserem J; Gradil C; Bassi S; Tolias CM
    Br J Neurosurg; 2019 Apr; 33(2):161-164. PubMed ID: 28616936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical Treatment for Patients with Moyamoya Syndrome and Type 1 Neurofibromatosis.
    Porras JL; Yang W; Garzon-Muvdi T; Xu R; Blakeley J; Belzberg A; Caplan JM; Khalid S; Colby GP; Coon AL; Tamargo RJ; Ahn ES; Huang J
    World Neurosurg; 2017 Mar; 99():19-25. PubMed ID: 27876659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct versus indirect bypass procedure for the treatment of ischemic moyamoya disease: results of an individualized selection strategy.
    Nielsen TH; Abhinav K; Sussman ES; Han SS; Weng Y; Bell-Stephens T; ; Heit JJ; Steinberg GK
    J Neurosurg; 2020 Jun; 134(5):1578-1589. PubMed ID: 32534489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moyamoya syndrome associated with Down syndrome: outcome after surgical revascularization.
    Jea A; Smith ER; Robertson R; Scott RM
    Pediatrics; 2005 Nov; 116(5):e694-701. PubMed ID: 16263984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of moyamoya syndrome in patients with Noonan syndrome.
    Gupta M; Choudhri OA; Feroze AH; Do HM; Grant GA; Steinberg GK
    J Clin Neurosci; 2016 Jun; 28():107-11. PubMed ID: 26778511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of repeat revascularization surgery for moyamoya disease after an unsuccessful indirect revascularization. Clinical article.
    Pandey P; Steinberg GK
    J Neurosurg; 2011 Aug; 115(2):328-36. PubMed ID: 21529138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down syndrome and moyamoya: clinical presentation and surgical management.
    See AP; Ropper AE; Underberg DL; Robertson RL; Scott RM; Smith ER
    J Neurosurg Pediatr; 2015 Jul; 16(1):58-63. PubMed ID: 25837890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.